Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer.
about
A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings.Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resectionIdentification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms.Evaluating hepatocellular carcinoma cell lines for tumour samples using within-sample relative expression orderings of genes.A simple way to detect disease-associated cellular molecular alterations from mixed-cell blood samples.An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy.Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning.Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites.Identification of molecular alterations in leukocytes from gene expression profiles of peripheral whole blood of Alzheimer's disease.An individualized gene expression signature for prediction of lung adenocarcinoma metastases.Robust transcriptional signatures for low-input RNA samples based on relative expression orderings.Robust method for identification of prognostic gene signatures from gene expression profiles.Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma.Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer.
P2860
Q31056926-1563C612-DE2B-4EE9-B2D2-F3338D2EC4C7Q33683844-787A8510-8E6B-41A0-8436-2E89249B7EB5Q33771364-1456833D-78DF-4BAD-B833-201D8183681EQ36689052-355432DB-E79E-4240-9E21-8F7625B9EAC8Q36962398-584AF9D4-BF89-49C9-9512-E6DB0F03E3C3Q37269227-E89CA335-23C2-4D0D-9684-52E3E3B6B85DQ37499268-E5A8BFE8-8393-4898-A001-8171957C174EQ37619692-EE0C5CB4-20E2-4E62-99F2-E4485715B0C1Q37633624-A733A57F-1DAE-477D-8ABA-68A67E82F7FFQ37701656-74BBA9FF-4D58-45B5-8D6F-49C90FAB7BE1Q37708870-F0A9F7E9-00AF-43A7-A12D-F4DF69645FCDQ38704362-DA8C6827-313A-4C77-98A7-97DE69AC8660Q38959995-6234A855-CBB8-4EE5-9A69-35B6D60DAA96Q39180729-9DC0E292-7E66-4827-BCE1-F83B1AE1E400Q39590420-1F4C9B3C-1E8C-44C8-9D36-902A150F5040Q42101229-ADF754DA-8982-423D-B2E1-6456936A982AQ42244798-A91F3032-D9AA-48E7-9C5B-F5E90E29CACDQ42630478-FFDEF4F2-07D5-4082-BF19-30AA304C73BDQ43985337-BA8EE409-02B4-46F7-B672-7F9F07C79BB7Q47093769-C2CD8A33-D189-46AD-9CA4-03123ACEEFC5Q47103384-E65D72C2-8E7E-4668-866D-CD1480756E8CQ47393395-2B04133E-CFEF-449E-AE82-6A8F6252D7DCQ49247828-99A68C54-99E3-4AE8-BAB1-2091EAB8F83BQ55315465-4B0F69BC-AB5D-4BDD-9925-D7D197F1983D
P2860
Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Critical limitations of progno ...... I non-small-cell lung cancer.
@en
type
label
Critical limitations of progno ...... I non-small-cell lung cancer.
@en
prefLabel
Critical limitations of progno ...... I non-small-cell lung cancer.
@en
P2093
P2860
P356
P1476
Critical limitations of progno ...... I non-small-cell lung cancer.
@en
P2093
Hongwei Wang
Libin Chen
Lishuang Qi
Ruiping Wang
Wenyuan Zhao
Xiangqi Chen
P2860
P304
P356
10.1093/BIB/BBV064
P577
2015-08-06T00:00:00Z